Cherry Biolabs’ Exclusive Sub-Licence Agreement With MorphoSys AG

CMS advised Cherry Biolabs on all legal aspects of the licence agreement. Biotech company Cherry Biolabs, a spin-off from Würzburg University Hospital and an exclusive licensee…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here